Patients With Acute Renal Failure During Severe COVID-19

NCT05077163 | Unknown

• 1 other identifier: 8039
• Study Type: observational
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The occurrence of renal failure during severe forms of COVID-19 is common (20-35% of patients treated in intensive care) and associated with an unfavorable short-term prognosis, but the medium-term renal outcome is not is not known. The aim of the study is to establish the frequency of chronic kidney failure after AKI KDIGO 2 and 3 occurring during severe COVID-19 in intensive care.

Conditions

Renal Failure Chronic

Keywords

COVID-19; SARS-COV-2; Renal failure

Outcome Measures

Primary Outcomes (1)

• Retrospective study of renal development in patients with acute renal failure during severe COVID-19

  Files analysed retrospectively from February 01, 2020 to July 31, 2020 will be examined]

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

\- Major subject hospitalized in an intensive care unit, Strasbourg, Nancy or Reims Hospitals, for severe COVID-19 between February 1, 2020 and July 31, 2020.

You may qualify if:

• Major subject (≥18 years old)
• Subject hospitalized in an intensive care unit, Strasbourg, Nancy or Reims hospitals, for severe COVID-19 between February 1, 2020 and July 31, 2020.
• Having presented acute renal failure KDIGO 2 (assessed on a doubling of serum creatinine compared to the patient's reference values) or 3 (serum creatinine greater than 3 times the patient's reference, or anuria, or any recourse to extra-purification renal)
• Having left hospital alive after initial treatment for COVID-19
• Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

You may not qualify if:

• Subject having expressed opposition to participating in the study
• Subject under guardianship or guardianship
• Subject under safeguard of justice

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, Chronic; COVID-19; Renal Insufficiency

Condition Hierarchy (Ancestors)

Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Bruno MOULIN, MD, PhD

  Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Bruno MOULIN, MD, PhD

CONTACT

33 3 69 55 05 11; Bruno.Moulin@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR

CONTACT

said.chayer@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 13, 2021
• First Posted: October 14, 2021
• Study Start: December 1, 2020
• Primary Completion: December 1, 2021
• Study Completion: December 1, 2021
• Last Updated: October 14, 2021

Record last verified: 2021-10

Locations

FR (1)